Menu
Call anytime
Achalasia cardia is a rare esophageal motility disorder characterized by the inability of the lower esophageal sphincter (LES) to relax properly, leading to difficulty in swallowing, regurgitation, and chest pain. Treatment aims to alleviate symptoms and improve esophageal function.
Procedure Overview:
Endoscopic Procedures: Endoscopic treatments for achalasia include pneumatic dilation and botulinum toxin injection. Pneumatic dilation involves using a balloon to stretch the LES, while botulinum toxin injection relaxes the sphincter muscle temporarily. These procedures aim to improve esophageal emptying and reduce symptoms.
Surgical Myotomy: Surgical myotomy is a more invasive treatment option where the LES muscle is cut or partially removed to reduce its pressure and allow for easier passage of food into the stomach. This procedure can be performed via laparoscopic or robotic-assisted techniques, offering precision and minimizing tissue trauma.
Benefits of Achalasia Cardia Treatment:
Hospital Care Following Achalasia Cardia Treatment:
Patients undergoing treatment for achalasia cardia require specialized hospital care to monitor for complications, manage symptoms, and support post-treatment recovery.
Postoperative Care may include:
Conclusion:
Effective management of achalasia cardia requires a multidisciplinary approach aimed at improving symptoms, preventing complications, and enhancing quality of life. With appropriate treatment and postoperative care, patients can experience significant relief from symptoms and improved swallowing function.
Subscribe to get latest update & news